Track Minerva Surgical Inc. Common Stock — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Minerva Surgical Inc. Common Stock UTRS Open Minerva Surgical Inc. Common Stock in new tab

0.000100 USD
EPS
-7.61
P/B
0.00
ROE
-160.08
Beta
82.84
1M 6M YTD 1Y 2Y 5Y Max
Loading chart...
Key Metrics
Earnings dateAug. 6, 2026
EPS-7.61
Book Value2.28
Price to Book0.00
Debt/Equity215.01
Growth
Revenue Growth-0.05%
Estimates
Forward P/E0.00
Forward EPS-2.89

DCF Valuation

Tweak assumptions to recompute fair value for Minerva Surgical Inc. Common Stock (UTRS)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result
Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Minerva Surgical Inc. Common Stock Logo Minerva Surgical Inc. Common Stock Analysis (UTRS)

United States Information Technology Official Website Stock

Is Minerva Surgical Inc. Common Stock a good investment? Minerva Surgical Inc. Common Stock (UTRS) is currently trading at 0.000100 USD.

Earnings Schedule: Minerva Surgical Inc. Common Stock is expected to release its next earnings report on Aug. 6, 2026. The market consensus estimate for Forward EPS is -2.89.

Investor FAQ

Does Minerva Surgical Inc. Common Stock pay a dividend?

No, it does not currently pay a dividend.

What asset class is Minerva Surgical Inc. Common Stock?

Minerva Surgical Inc. Common Stock is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be Aug. 6, 2026. The company currently has a trailing EPS of -7.61.

Company Profile

Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company provides Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California.

Exchange Ticker
NMS (United States) UTRS
STO (Sweden) ARCT.ST

Dividends

Historical Split Corporate Actions

Split Date Split Ratio to 1
Oct. 2, 2023 0.050000
Trades
Trade History
No trades yet
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion